Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,17102,706,1.12 [0.97-1.29],0.1316801218265082
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16556,199,1.36 [1.09-1.69],0.0068905886424445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18888,120,1.15 [0.82-1.60],0.4167310134064849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12728,658,1.21 [1.04-1.40],0.0119633712150341
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18852,84,1.17 [0.79-1.73],0.424147787791282
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17162,69,1.38 [0.96-1.99],0.0862998773105489
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19719,83,1.19 [0.81-1.75],0.3820573421580261
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19730,56,0.95 [0.55-1.63],0.8430116607459839
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16810,47,1.59 [1.08-2.35],0.0180407599878737
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18933,97,1.26 [0.89-1.78],0.1936835866244923
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18900,64,1.47 [1.02-2.13],0.0398573863054588
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19786,50,1.46 [0.95-2.22],0.0809047034940173
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19808,62,0.66 [0.37-1.18],0.1584135506593047
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19800,54,0.71 [0.39-1.32],0.2830783600527853
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,19541,37,0.92 [0.47-1.80],0.8136247490614497
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18776,333,1.27 [1.05-1.52],0.0132405233167286
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18571,128,1.08 [0.78-1.51],0.6297498878442157
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18671,228,1.33 [1.08-1.65],0.0081843648391029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",15523,61,1.42 [0.97-2.08],0.069284909460879
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15499,37,1.40 [0.87-2.25],0.1694222769650631
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15680,218,0.86 [0.65-1.15],0.3114013856400381
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15686,224,0.87 [0.66-1.16],0.345480395524037
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15653,191,0.99 [0.75-1.32],0.9661818543125186
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15503,41,1.40 [0.88-2.24],0.1575975986010706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,17671,442,1.21 [1.02-1.44],0.0263023245528784
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18532,316,1.13 [0.92-1.39],0.2387772646304475
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19285,106,1.20 [0.85-1.67],0.2972022586137668
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19844,111,1.16 [0.83-1.63],0.3933604820193002
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,19555,65,1.07 [0.67-1.71],0.7682668054419919
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19851,57,1.31 [0.85-2.02],0.2150303530724437
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Stomach,19891,40,1.24 [0.72-2.13],0.444574085361044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,19617,257,1.14 [0.91-1.43],0.2636055547621471
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19859,93,1.09 [0.74-1.61],0.6649488481405954
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19866,59,1.38 [0.92-2.07],0.1196839975493995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19828,31,0.94 [0.45-1.94],0.8581680770142277
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",19831,31,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,19766,100,1.29 [0.92-1.80],0.1357018996886323
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19881,39,1.28 [0.74-2.19],0.3748399418108502
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,19785,113,0.83 [0.55-1.24],0.3585967784572088
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18939,95,1.44 [1.06-1.97],0.0193338028514122
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,18634,197,1.22 [0.95-1.56],0.1257790737492591
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,18634,197,1.22 [0.95-1.56],0.1257790737492591
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),16786,409,0.80 [0.65-1.00],0.0457910860987434
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19470,35,1.20 [0.67-2.17],0.5358939715390484
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19687,49,1.07 [0.62-1.84],0.8162887687513538
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,15608,1165,1.15 [1.02-1.29],0.0173248887270143
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19324,152,0.88 [0.62-1.23],0.4453979335873912
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17544,107,0.96 [0.65-1.40],0.8161185730605485
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18774,141,1.04 [0.75-1.44],0.8054498251223149
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17534,97,1.03 [0.70-1.51],0.8844281081487493
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,17995,558,1.05 [0.89-1.24],0.5925768987730814
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,17979,542,1.05 [0.88-1.24],0.5949857509566853
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,18438,139,1.07 [0.75-1.51],0.723255051995015
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",18438,138,1.07 [0.75-1.51],0.7188491567445909
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,15485,1042,1.13 [1.00-1.27],0.0542548532457628
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14586,143,1.19 [0.89-1.61],0.2436549954147029
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,15404,961,1.10 [0.97-1.25],0.1320239477394159
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14482,39,1.88 [1.31-2.70],0.0006377013995832
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14520,77,1.40 [0.98-2.00],0.0624810961559359
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,16919,587,1.03 [0.87-1.22],0.7436814069393509
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16636,304,0.97 [0.76-1.24],0.7877773967754276
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19430,231,0.92 [0.70-1.21],0.5492350032865401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19499,176,0.90 [0.66-1.25],0.5355445213365067
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18129,71,0.97 [0.60-1.58],0.9176729716695824
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19772,71,0.97 [0.60-1.57],0.8888847162019397
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",16403,71,1.00 [0.61-1.62],0.9913169245825288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Alcohol dependence,18158,100,0.80 [0.52-1.25],0.3282528121723821
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,18132,77,1.11 [0.72-1.72],0.6368783276483302
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16391,59,0.95 [0.55-1.63],0.8520068297060165
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16549,217,1.01 [0.77-1.32],0.9615695203160164
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression,18904,186,0.97 [0.72-1.30],0.8237673389744946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression or dysthymia,16332,164,0.95 [0.69-1.31],0.7594052243861847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16421,89,1.05 [0.70-1.57],0.8211325411752516
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Other anxiety disorders,19050,46,0.70 [0.36-1.37],0.2996063908639144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,16983,1117,1.04 [0.92-1.18],0.5064313406573244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15292,76,1.40 [0.98-1.99],0.0644353075426169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19804,56,1.39 [0.92-2.09],0.1216219470283896
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18797,448,0.98 [0.81-1.19],0.8654469788876481
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,18488,139,1.04 [0.75-1.44],0.8088054443163589
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,18377,28,1.15 [0.58-2.28],0.6924446716363339
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19760,21,0.92 [0.37-2.27],0.859522567269078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19101,81,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,18544,195,0.88 [0.65-1.19],0.3983182547763454
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,19295,154,0.88 [0.62-1.24],0.45610855557142
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19103,404,1.16 [0.97-1.39],0.106202206463533
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18804,105,1.23 [0.87-1.73],0.2354601364380706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18890,191,0.96 [0.72-1.29],0.8059937979802645
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19623,77,0.81 [0.49-1.32],0.3942551545414401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,19596,50,0.83 [0.45-1.52],0.5497371150323414
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,19481,101,0.69 [0.44-1.08],0.1071337659581704
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19402,263,1.07 [0.85-1.35],0.5733838863018472
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19289,150,0.77 [0.54-1.11],0.1563428372255623
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19206,67,1.21 [0.78-1.86],0.3923458709952547
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19224,85,0.78 [0.48-1.26],0.3049312540207995
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19178,39,1.53 [0.98-2.38],0.0611899701553249
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17438,113,1.18 [0.84-1.65],0.3393955437925533
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17638,313,1.13 [0.91-1.39],0.2660230672849777
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19078,192,1.31 [1.03-1.66],0.0254184275697634
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19549,41,1.55 [1.01-2.38],0.0465000173273363
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2169,41,1.74 [1.08-2.80],0.0223877381963053
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17421,41,1.49 [0.96-2.29],0.0727554852661704
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19330,79,1.11 [0.73-1.68],0.6317539594751947
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19291,40,0.90 [0.47-1.74],0.7540836046898094
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19442,60,0.66 [0.37-1.20],0.1706432468722409
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19472,83,0.75 [0.46-1.22],0.2418550201644032
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19810,115,0.87 [0.59-1.29],0.4898846504989196
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,19129,87,0.88 [0.57-1.38],0.582137567852979
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,13385,3071,1.07 [0.98-1.18],0.1346552388646444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19327,50,1.39 [0.91-2.14],0.127854104587946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14163,2006,1.11 [1.00-1.22],0.0508426720254581
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,14188,2031,1.11 [1.00-1.22],0.0461535092442752
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12218,61,1.71 [1.18-2.49],0.0045020777675595
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17623,1355,1.13 [1.01-1.26],0.0290380418549224
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,17014,746,1.18 [1.03-1.36],0.018921515442567
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18700,268,1.07 [0.85-1.35],0.5720704521184254
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19026,594,1.06 [0.90-1.24],0.501234154547121
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19719,140,1.03 [0.75-1.43],0.8443320297462918
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16681,413,1.10 [0.91-1.33],0.3312705045017334
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17402,1155,1.10 [0.98-1.24],0.1179271706988365
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19175,102,1.16 [0.81-1.65],0.4103996736755719
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19278,207,0.98 [0.75-1.29],0.9020321341579848
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19148,75,0.83 [0.51-1.36],0.4654091652492399
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19149,76,0.84 [0.52-1.37],0.4883485045916587
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12229,72,0.90 [0.55-1.47],0.6609838148135583
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15648,69,0.98 [0.60-1.59],0.9284191562171
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,15716,137,1.32 [1.00-1.75],0.0484430763481066
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9863,112,1.12 [0.77-1.62],0.560188498804931
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10254,503,1.01 [0.83-1.23],0.9281233203674246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,15650,71,1.15 [0.75-1.77],0.521801125937962
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15688,109,1.03 [0.71-1.50],0.8581168185237159
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18821,267,1.15 [0.92-1.43],0.2164072273733196
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19046,146,0.74 [0.51-1.07],0.1075687546732786
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19067,133,0.76 [0.52-1.12],0.1646887403821437
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19137,117,0.79 [0.53-1.19],0.259931399188544
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18741,67,1.39 [0.95-2.03],0.0910482222609224
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18800,126,0.95 [0.66-1.37],0.7846565258674972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18787,130,1.02 [0.72-1.43],0.9142974656713972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18771,114,0.84 [0.56-1.25],0.3861617784302122
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19701,107,0.86 [0.57-1.29],0.4528302830708389
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,18947,290,1.25 [1.02-1.53],0.0281109695372381
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,18871,66,1.14 [0.73-1.79],0.5630669035295512
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,15549,1701,1.00 [0.91-1.11],0.9499278021538288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19751,73,1.06 [0.67-1.65],0.8126186215528721
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,18188,214,1.15 [0.90-1.47],0.2601721862551236
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",18152,178,1.07 [0.81-1.42],0.6201528953811904
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19105,235,1.16 [0.92-1.47],0.2028555215304502
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19103,233,1.18 [0.93-1.49],0.1633877118551147
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19155,555,0.94 [0.79-1.12],0.4889479492368296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,18662,62,1.41 [0.95-2.08],0.0881226953085895
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,18742,142,1.06 [0.77-1.46],0.7389598442924887
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18952,352,0.88 [0.70-1.10],0.2539467717823299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,18790,190,0.94 [0.70-1.27],0.7046984613052155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8670,47,0.72 [0.37-1.39],0.3278079998868644
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,17777,719,0.98 [0.84-1.14],0.7948864438531238
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,18794,163,1.03 [0.76-1.39],0.8715192112026318
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18819,188,0.92 [0.68-1.23],0.5639766591063404
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18819,188,0.92 [0.68-1.23],0.5639766591063404
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18712,552,1.04 [0.88-1.22],0.6846108796856967
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Asthma,13527,552,1.04 [0.88-1.23],0.662331726487148
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13240,552,1.05 [0.89-1.25],0.5491768486886874
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13517,542,1.03 [0.87-1.23],0.7195488056576804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19523,93,1.06 [0.72-1.57],0.7541928871029173
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,18889,72,0.68 [0.40-1.16],0.1602574159946246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19591,72,0.68 [0.40-1.16],0.1584716408625375
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18883,66,0.79 [0.46-1.34],0.3852984957722573
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,17959,115,1.19 [0.86-1.66],0.2963070248037219
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,18086,242,1.07 [0.84-1.37],0.5641265935618336
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18750,107,0.79 [0.52-1.20],0.2665635093470644
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,13263,4676,1.07 [0.99-1.15],0.0852998278692053
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19493,305,1.06 [0.85-1.32],0.6155244439775805
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19874,61,1.11 [0.69-1.79],0.6723844566694206
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,19875,58,1.13 [0.70-1.83],0.6224744757380132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,19284,96,1.03 [0.69-1.53],0.8929614222381331
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19251,63,0.98 [0.59-1.62],0.9359665471638168
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19869,70,1.19 [0.78-1.83],0.4130017567279798
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19250,62,0.69 [0.39-1.24],0.2152468532314875
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19069,69,0.99 [0.61-1.59],0.9638700754189736
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19820,51,0.77 [0.41-1.42],0.4004145838871721
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15282,268,1.26 [1.02-1.55],0.0297251952657886
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",16694,1680,1.06 [0.96-1.17],0.2822277903679966
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,15342,328,1.01 [0.81-1.25],0.9418026125887252
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15571,557,1.14 [0.97-1.33],0.1058516701128179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15083,69,1.34 [0.91-1.97],0.1330019418903921
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15253,239,0.94 [0.72-1.22],0.6273017843989789
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15080,66,0.64 [0.36-1.14],0.129210024889202
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,15140,126,1.36 [1.03-1.80],0.0306679255813468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,15165,151,1.28 [0.97-1.68],0.0805227724678217
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19742,103,1.41 [1.05-1.91],0.0242292912411136
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,15117,103,0.84 [0.55-1.28],0.4176663403426911
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15662,648,1.00 [0.85-1.17],0.995471696705312
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,19762,86,0.96 [0.62-1.48],0.8406783523631814
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,15259,245,1.09 [0.86-1.39],0.4863816281222629
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15151,137,1.02 [0.73-1.42],0.9178271196985204
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19722,150,0.99 [0.71-1.37],0.9519586769389768
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,19744,68,1.04 [0.65-1.67],0.8595288155760274
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,16993,1713,1.00 [0.91-1.11],0.9460829834436592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,16232,952,0.97 [0.84-1.10],0.608207670702839
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,15422,142,1.22 [0.91-1.63],0.1756473805720767
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,15358,78,1.06 [0.69-1.61],0.8038558170388026
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15920,640,1.00 [0.86-1.17],0.9556615038912508
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19169,512,1.19 [1.01-1.39],0.0361131567729351
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,15369,1517,1.15 [1.04-1.27],0.0073489956387947
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19611,45,1.57 [1.05-2.35],0.0290234571899163
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19833,58,1.53 [1.06-2.21],0.0225453601078108
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,18715,58,1.54 [1.07-2.22],0.0206364240224521
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18703,46,1.70 [1.18-2.46],0.00480187001449
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19785,121,1.10 [0.78-1.54],0.580601564885314
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,18778,121,1.11 [0.79-1.56],0.5420362069799789
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18766,109,1.08 [0.75-1.55],0.6902626915294963
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19047,390,1.20 [1.00-1.43],0.0532202467229888
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19045,388,1.20 [1.00-1.43],0.0516760568117375
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13933,81,1.36 [0.95-1.95],0.0884764682841943
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal stricture,19520,81,1.34 [0.94-1.90],0.1083384397355975
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13912,60,1.52 [1.04-2.21],0.0292660391208311
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,14286,434,1.23 [1.03-1.47],0.0201142645936742
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13930,78,0.98 [0.62-1.54],0.923567264633104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14005,153,1.32 [1.01-1.74],0.042373474454931
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,18620,139,1.29 [0.97-1.71],0.0783893023531159
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19565,42,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,13994,142,0.94 [0.66-1.33],0.7106389871618659
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13937,85,1.17 [0.79-1.73],0.4371515433225994
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14576,724,1.07 [0.92-1.24],0.3780878477898594
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,14113,261,1.07 [0.84-1.36],0.595033080306745
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19554,31,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,19185,117,1.37 [1.02-1.85],0.0385805646935916
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,19133,65,1.62 [1.17-2.26],0.0041353975884209
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18911,298,1.14 [0.92-1.41],0.2175188574514847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,18827,214,1.30 [1.04-1.63],0.0231854119778627
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,18663,50,0.53 [0.27-1.04],0.0662087652898132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18636,23,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,18673,60,1.32 [0.86-2.00],0.2011189158213259
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19719,60,1.31 [0.86-2.00],0.2060219047587469
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18723,271,1.15 [0.92-1.43],0.2194397074641636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18480,28,1.11 [0.55-2.23],0.7759354109796032
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,18473,21,1.33 [0.67-2.66],0.4188593861416311
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18501,49,1.29 [0.81-2.05],0.2810072083866803
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18652,200,1.13 [0.87-1.47],0.3537569926593678
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,18648,196,1.14 [0.88-1.48],0.3271490681198947
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,17309,1264,1.17 [1.05-1.30],0.0046878375593702
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19522,83,0.85 [0.53-1.35],0.482423335555457
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19576,386,1.12 [0.93-1.35],0.2384223497459592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18591,393,1.11 [0.92-1.34],0.2640646651635372
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19050,398,1.25 [1.05-1.49],0.010780393958572
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18742,90,1.27 [0.89-1.82],0.1840506648830415
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18903,251,1.33 [1.08-1.64],0.0065279779913105
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19663,77,1.17 [0.78-1.75],0.4509339124400953
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19650,64,1.21 [0.78-1.86],0.3918182422723562
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19636,50,1.16 [0.70-1.91],0.5699990208701272
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19628,40,0.94 [0.50-1.79],0.858770320371146
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19627,39,0.92 [0.47-1.76],0.7909478108660895
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19240,50,0.78 [0.42-1.45],0.4298080714645131
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19503,313,1.18 [0.96-1.44],0.115937934037613
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18273,75,1.39 [0.98-1.98],0.0646835706640706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18236,38,1.33 [0.79-2.25],0.2823641195880626
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18233,35,1.34 [0.77-2.31],0.2979891884126779
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18352,154,0.87 [0.62-1.22],0.417905337423837
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18338,140,0.82 [0.57-1.18],0.2857863980413904
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14717,2965,1.01 [0.93-1.10],0.8098362389380502
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,15935,1757,1.03 [0.93-1.14],0.5801037842998787
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18027,907,0.97 [0.84-1.11],0.6510432194003929
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14248,70,0.89 [0.55-1.46],0.6566131903593975
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14509,331,1.03 [0.83-1.27],0.8098208048367913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19657,67,0.93 [0.56-1.53],0.7692677477050944
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19659,58,1.05 [0.64-1.73],0.8489744411427531
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15062,884,0.98 [0.85-1.12],0.755145847619604
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17108,884,0.98 [0.85-1.12],0.7445646527227892
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14286,108,1.17 [0.83-1.65],0.3768714164880022
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19113,104,1.18 [0.83-1.67],0.3619501682244467
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14307,129,0.99 [0.70-1.40],0.956716213100418
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14223,45,0.42 [0.20-0.87],0.0198527710557273
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14390,212,0.96 [0.73-1.26],0.7637398252887194
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19781,106,0.95 [0.64-1.40],0.782515808168703
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14660,482,1.01 [0.84-1.21],0.9031325257843604
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14421,243,1.00 [0.78-1.29],0.985630006502436
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15159,981,1.03 [0.90-1.17],0.704516251262368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14198,20,0.91 [0.36-2.28],0.8373319120022396
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14217,39,1.01 [0.54-1.89],0.9784107577150029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14200,22,1.23 [0.61-2.46],0.5623011943690879
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14190,12,0.79 [0.22-2.75],0.7077341974857234
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14683,505,1.08 [0.91-1.28],0.3643692600260171
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14619,441,1.08 [0.90-1.29],0.4288862263613615
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16104,221,0.90 [0.68-1.19],0.4717677178286978
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19649,35,0.86 [0.42-1.76],0.6796335335890864
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19629,15,0.29 [0.08-1.04],0.0581327500623855
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17437,32,0.77 [0.36-1.67],0.5101113492104352
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17645,240,0.77 [0.58-1.02],0.0656116162943609
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18092,687,0.93 [0.79-1.09],0.3451917219124698
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17540,135,0.71 [0.48-1.04],0.0800842671757753
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17480,75,0.67 [0.40-1.14],0.1402042328489327
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17943,538,0.95 [0.80-1.14],0.599016604091582
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17451,46,1.04 [0.59-1.83],0.8946423187835777
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17594,189,1.04 [0.78-1.37],0.7978015124527353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17487,82,1.41 [1.01-1.99],0.0461240701894165
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17461,56,0.97 [0.57-1.65],0.9032802845107788
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17506,101,0.95 [0.63-1.41],0.7843513285042156
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17446,41,0.76 [0.38-1.51],0.4267931838943403
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17615,210,0.96 [0.72-1.26],0.74728204521079
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17317,197,0.89 [0.66-1.20],0.458297265100603
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17169,49,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17176,56,0.97 [0.57-1.66],0.9162706197146344
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17172,52,1.54 [1.03-2.32],0.0369310837297598
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17171,51,1.37 [0.87-2.16],0.1683400844805027
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17266,146,1.05 [0.76-1.44],0.7696149279787179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17258,138,1.10 [0.80-1.51],0.5623959030918009
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17324,204,0.89 [0.66-1.19],0.4247062256417296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17165,45,1.28 [0.77-2.13],0.3395553222310034
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17192,72,0.63 [0.36-1.09],0.0986282079180191
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17215,95,0.80 [0.51-1.25],0.3199384249116646
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17158,38,1.27 [0.73-2.21],0.3885140740629995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17414,294,0.95 [0.75-1.20],0.6640504609248845
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17243,123,1.04 [0.73-1.47],0.8268525980805161
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17279,159,1.05 [0.78-1.43],0.7372329670490694
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19054,87,1.23 [0.85-1.77],0.2759225180490893
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19210,243,1.08 [0.84-1.37],0.5540123986553045
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19010,43,0.51 [0.24-1.05],0.066738568912099
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19013,46,1.08 [0.62-1.88],0.7937938471696396
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19045,78,1.17 [0.78-1.75],0.451958356201274
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,15299,1905,1.13 [1.03-1.24],0.0114263637638033
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17149,1047,1.12 [0.99-1.26],0.0769216653066545
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,17681,214,1.33 [1.07-1.67],0.0106488016527289
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17536,69,1.04 [0.66-1.64],0.8633573837350832
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,17736,51,1.31 [0.82-2.08],0.2562790292009671
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,17738,53,2.03 [1.53-2.69],1.049296077524345e-06
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17752,67,1.69 [1.23-2.30],0.0010059478496661
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19469,289,0.87 [0.68-1.12],0.2783650725246479
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19472,59,1.55 [1.08-2.24],0.0177738401276306
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19384,204,0.68 [0.49-0.93],0.0164041039910976
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19290,110,1.17 [0.83-1.65],0.3626087175613153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18065,683,1.14 [0.99-1.31],0.0718219571813188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,17427,45,0.90 [0.48-1.67],0.7351862045974489
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17443,61,0.99 [0.60-1.63],0.962061493906626
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17692,310,1.21 [1.00-1.48],0.0554257810094163
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17490,108,1.18 [0.84-1.66],0.3326983232506751
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17694,312,1.12 [0.91-1.39],0.2712348117381039
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16573,471,1.09 [0.91-1.30],0.3660255012207646
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16187,85,1.54 [1.12-2.10],0.0071872764226526
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,16185,83,1.27 [0.87-1.85],0.2217300893202738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16234,132,1.00 [0.70-1.41],0.9823458881418696
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16236,134,1.24 [0.92-1.67],0.1585404288572509
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16268,166,0.95 [0.69-1.30],0.73181890770796
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19486,61,0.75 [0.43-1.33],0.327000057417422
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18143,465,1.09 [0.92-1.30],0.3121168019234738
